These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 23179835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Derivation and characterization of murine alternatively activated (M2) macrophages.
    Ho VW, Sly LM.
    Methods Mol Biol; 2009; 531():173-85. PubMed ID: 19347318
    [Abstract] [Full Text] [Related]

  • 3. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states.
    Mulder R, Banete A, Basta S.
    Immunobiology; 2014 Oct; 219(10):737-45. PubMed ID: 24954891
    [Abstract] [Full Text] [Related]

  • 4. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
    Munder M, Eichmann K, Modolell M.
    J Immunol; 1998 Jun 01; 160(11):5347-54. PubMed ID: 9605134
    [Abstract] [Full Text] [Related]

  • 5. Azithromycin alters macrophage phenotype.
    Murphy BS, Sundareshan V, Cory TJ, Hayes D, Anstead MI, Feola DJ.
    J Antimicrob Chemother; 2008 Mar 01; 61(3):554-60. PubMed ID: 18230686
    [Abstract] [Full Text] [Related]

  • 6. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
    Jaguin M, Houlbert N, Fardel O, Lecureur V.
    Cell Immunol; 2013 Jan 01; 281(1):51-61. PubMed ID: 23454681
    [Abstract] [Full Text] [Related]

  • 7. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
    Ghosh M, Xu Y, Pearse DD.
    J Neuroinflammation; 2016 Jan 13; 13():9. PubMed ID: 26757726
    [Abstract] [Full Text] [Related]

  • 8. Macrophage activation: classical versus alternative.
    Classen A, Lloberas J, Celada A.
    Methods Mol Biol; 2009 Jan 13; 531():29-43. PubMed ID: 19347309
    [Abstract] [Full Text] [Related]

  • 9. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.
    Munder M, Eichmann K, Morán JM, Centeno F, Soler G, Modolell M.
    J Immunol; 1999 Oct 01; 163(7):3771-7. PubMed ID: 10490974
    [Abstract] [Full Text] [Related]

  • 10. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
    Holán V, Pindjáková J, Krulová M, Neuwirth A, Fric J, Zajícová A.
    Transplantation; 2006 Jun 27; 81(12):1708-15. PubMed ID: 16794538
    [Abstract] [Full Text] [Related]

  • 11. Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages.
    Xu YW, Xing RX, Zhang WH, Li L, Wu Y, Hu J, Wang C, Luo QL, Shen JL, Chen X.
    World J Gastroenterol; 2019 Dec 07; 25(45):6634-6652. PubMed ID: 31832003
    [Abstract] [Full Text] [Related]

  • 12. Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages.
    Guzmán-Morales J, Ariganello MB, Hammami I, Thibault M, Jolicoeur M, Hoemann CD.
    Biochem Biophys Res Commun; 2011 Feb 25; 405(4):538-44. PubMed ID: 21256824
    [Abstract] [Full Text] [Related]

  • 13. Suppression of IFNgamma+mycobacterial lipoarabinomannan-induced NO by IL-4 is due to decreased IRF-1 expression.
    Morris KR, Lutz RD, Bai X, McGibney MT, Cook D, Ordway D, Chan ED.
    Tuberculosis (Edinb); 2009 Jul 25; 89(4):294-303. PubMed ID: 19556165
    [Abstract] [Full Text] [Related]

  • 14. Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure.
    Zeidler PC, Roberts JR, Castranova V, Chen F, Butterworth L, Andrew ME, Robinson VA, Porter DW.
    J Toxicol Environ Health A; 2003 Jun 13; 66(11):995-1013. PubMed ID: 12775513
    [Abstract] [Full Text] [Related]

  • 15. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
    El Hadri K, Mahmood DF, Couchie D, Jguirim-Souissi I, Genze F, Diderot V, Syrovets T, Lunov O, Simmet T, Rouis M.
    Arterioscler Thromb Vasc Biol; 2012 Jun 13; 32(6):1445-52. PubMed ID: 22516068
    [Abstract] [Full Text] [Related]

  • 16. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
    Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T.
    Am J Respir Cell Mol Biol; 2009 Nov 13; 41(5):590-602. PubMed ID: 19244203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.
    Holden JA, Attard TJ, Laughton KM, Mansell A, O'Brien-Simpson NM, Reynolds EC.
    Infect Immun; 2014 Oct 13; 82(10):4190-203. PubMed ID: 25047849
    [Abstract] [Full Text] [Related]

  • 20. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
    Choi JW, Kwon MJ, Kim IH, Kim YM, Lee MK, Nam TJ.
    Int J Mol Med; 2016 Aug 13; 38(2):666-74. PubMed ID: 27353313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.